TG Therapeutics Inc (TGTX)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 4.33 | — | 4.82 | — | — | |
| DSO | days | 84.37 | — | 75.79 | — | — |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.33
= 84.37
The Days Sales Outstanding (DSO) ratio indicates the average number of days it takes for a company to collect its accounts receivable.
TG Therapeutics Inc's DSO trend over the years is as follows:
- Dec 31, 2023: 84.37 days
- Dec 31, 2022: Data not available
- Dec 31, 2021: 75.79 days
- Dec 31, 2020: Data not available
- Dec 31, 2019: Data not available
The increase in DSO from 75.79 days in 2021 to 84.37 days in 2023 suggests that the company may be taking longer to collect its accounts receivable. This could potentially indicate liquidity or credit risk as it may be facing challenges in converting sales into cash. It is important for the company to monitor its DSO closely to ensure efficient management of its accounts receivable and timely collection of outstanding balances.
Peer comparison
Dec 31, 2023